Clinical Trials Browser

Neoplasms × Rifampin × Thoracic × Clear all

NCT02197247 2021-07-12

Study to Assess the Effect of Rifampicin on Blood Levels and Safety of AZD9291, in Patients With EGFRm+ NSCLC

Phase 1 Completed

41 enrolled 24 charts

Carcinoma, Non-Small-Cell Lung, Neoplasms